New Drugs & OTCs

03/21/2014 - 12:10pm

Skinnygirl brand has already made its foray into several categories, including a recent line of water flavor enhancers and a partnership with SodaStream to create new flavors. Now the brand will step into the supplement category with its new Skinnygirl Supplements.

03/21/2014 - 8:48am

Danish pharmaceutical group Alk Abello, in association with Merck, expects to start selling its new dust mite allergy tablet in the United States in 2017, according to a Reuters report published Thursday.

03/20/2014 - 10:38am

The Food and Drug Administration announced the approval of Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Leishmaniasis is caused by Leishmania, a parasite transmitted to humans through sand fly bites.

03/19/2014 - 9:23am

Heel Inc., a homeopathic pharmaceutical company, announced the debut of ClearLife allergy relief and WellMind calming and alertness aid brands.

03/18/2014 - 2:46pm

Natco Pharma received tentative approval from the Food and Drug Administration to launch a generic version of Roche Holding AG's Tamiflu, according to a recent report. The drug is used to treat bird and swine flu.

03/18/2014 - 2:00pm

Mallinckrodt Plc last week announced that the Food and Drug Administration approved Xartemis XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII), for the management of acute pain severe enough that it requires opioid treatment.

03/17/2014 - 1:38pm

Bristol-Myers Squibb Co. and Pfizer announced that the Food and Drug Administration approved a supplemental new drug application for Eliquis (apixaban). The drug is a preventive treatment for deep vein thrombosis, which can lead to pulmonary embolism for patients who have had hip or knee replacement surgery.

03/17/2014 - 11:03am

Pierre Fabre Dermatologies announced that it received authorization from the Food and Drug Administration to market the pediatric drug Hemangeol (propranolol hydrochloride).

03/13/2014 - 12:02pm

Perrigo announced the launch of methazolamide tablets, the generic version of Neptazane tablets. The product is a component of the rights the company received in connection with its acquisition of a portfolio of ophthalmic products from Fera Pharmaceuticals and its affiliates last year.

03/12/2014 - 2:37pm

Upsher-Smith has received approval from the Food and Drug Administration for Qudexy XR (topiramate) extended-release capsules, a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic profile.